EMMA-1 (Erbitux for Multiple Myeloma)

NCT00368121 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitable patients

Conditions

Multiple Myeloma

Interventions

DRUG: Cetuximab +/- Dexamethasone

Sponsor

Prof. Dr. Andreas Engert

Collaborators

[object Object]